CD7 and peripheral T-cell lymphoma, not otherwise specified: For T cell malignancies, the 40 kDa transmembrane glycoprotein CD7 is a particularly interesting target as it is expressed in ∼95% of T-ALL and ∼50% of peripheral T cell lymphomas.1